Stocks / RGNX
Stock profile · 銘柄

REGENXBIO Inc. - Common Stock (RGNX)

REGENXBIO Inc. - Common Stock (RGNX) last closed at $11.98 (as of 2026-06-30). On Shishin's four-engine momentum model it scored 61/100, flagged by the Suzaku engine (Extended) on its most recent scan appearance (2026-06-30). It has surfaced in 1 daily scan since 2026-06-30. The figures below are research data, the composite score and the momentum, trend, and volatility indicators the engines observe, not investment advice.

Price updates daily; the engine read reflects RGNX's most recent scan appearance. Shishin's live daily signals are published each morning on the rankings board.

Composite score61
Active engineSuzaku
SetupExtended
Current close$11.98
SectorBiotechnology
Price · last ~60 sessions
$11.833/64/176/30
Indicators · as of 2026-06-30
ADR · 20d10.0%
ATR · 147.3%
RSI · 1479
Return · 30d+89%
Return · 60d+37%
Above MA2052%
Above MA5046%
Range · 20d102%
MA stack2
From 52w high-27%
$ Vol · 30d$17M
Vol ratio1.11×
Frequently asked

What is RGNX's Shishin momentum score?

As of 2026-06-30, RGNX scores 61/100 on Shishin's four-engine composite, flagged by the Suzaku engine. The score blends momentum, trend, and volatility indicators on a 0 to 100 scale.

Is RGNX showing a momentum setup?

RGNX's current setup state is "Extended." This describes what the engines observe in the chart structure, it is a data classification, not a recommendation to buy or sell.

Which Shishin engine flags RGNX?

Most recently the Suzaku engine. Each of the four guardians is tuned for a different market regime.

How often has RGNX appeared in Shishin scans?

RGNX has appeared in 1 daily scan since 2026-06-30. Recurring appearances indicate a persistent setup; one-off appearances are more transient.

How is the Shishin score calculated?

The composite is a weighted blend of momentum (multi-horizon returns), trend (moving-average stack, distance from MAs), and volatility/liquidity (ADR, ATR, dollar volume) indicators, scored per the engine active for the current market regime.

Related reading

Research data, not investment advice. Shishin publishes what its systematic engines observe; it does not recommend buying or selling any security, and is not a registered investment adviser or broker-dealer. See our risk disclosure.

Today's full rankings →5-year track record →More Biotechnology momentum stocks →More Suzaku setups →All covered stocks →